CSI Market
Sign In | Register

Spyglass Pharma Inc (SGP) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SGP Annual Balance Sheets →
The data below summarizes Spyglass Pharma Inc's balance sheet position from Sep. 30, 2009 to Jun 30 2026, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Dec 31 2024) (Sep. 30, 2009)
Assets
Cash & cash equivalent223.14
Short-term investments0.00
Cash & Short-term Investments223.00
Accounts receivable0.00
Other Receivables, Net, Current0.68
Inventories0.00
Other current assets11.04
Income Taxes0.00
Prepaid Expense And Other Assets Current1.60
Total Current Assets236.46
Equipment/Property/Plant Net6.56
Goodwill net0.00
Intangible Assets0.00
Income Taxes0.00
Other Assets0.41
Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Current12.10
Operating Lease Right Of Use Asset1.49
Total Assets243.43
Liabilities
Accounts Payable, Current AC4.16
Employee-related Liabilities, Current AC1.72
Shortterm debt0.00
Other current liabilities3.56
Income & other taxes0.00
Total Current Liabilities9.44
Long-term debt0.00
Total Long-term Debt0.00
Preferred sec.0.00
Deferred income taxes0.00
Other longterm liabilities1.63
OperatingLeaseLiabilityNoncurrent1.61
Total Liabilities11.07
Stockholders' Equity
Additional Paid In Capital Common Stock370.78
Retained Earnings / Accumulated Deficit-138.41
Other Equity0.00
Common Stockholder's Equity232.36
Non-controlling interests & other0.00
Total Stockholder's Equity232.36
Liabilities & Stockholder's Equity243.43
4 historic quarters locked

Sign in to unlock the full Spyglass Pharma Inc balance sheet history.

Sign In Create Free Account

About Spyglass Pharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 6, 2026
  • Source: sgp-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001778922-26-000045

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.